Metal mediated protease inhibition: Design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease

Citation
D. Dhanak et al., Metal mediated protease inhibition: Design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease, BIOORG MED, 10(20), 2000, pp. 2279-2282
Citations number
23
Categorie Soggetti
Chemistry & Analysis
Journal title
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
ISSN journal
0960894X → ACNP
Volume
10
Issue
20
Year of publication
2000
Pages
2279 - 2282
Database
ISI
SICI code
0960-894X(20001016)10:20<2279:MMPIDA>2.0.ZU;2-A
Abstract
A versatile synthetic route to a novel series of bis-imidazolemethanes desi gned to inhibit the hCMV protease has been developed and a series of potent ial metal binding inhibitors has been identified. In selectivity assays, th e compounds were highly specific for CMV protease and showed no inhibition (IC50 >100 muM) Of Other prototypical serine proteases such as trypsin, ela stase, and chymotrypsin. Although the presence of free zinc ions was found to be an absolute requirement for the in vitro biological activity of this class of inhibitor, the potency of the inhibitors could not be improved bey ond the micromolar level. (C) 2000 Elsevier Science Ltd. All rights reserve d.